Nintedanib
|
|
Nintedanib 속성
- 녹는점
- >237oC (dec.)
- 끓는 점
- 742.2±60.0 °C(Predicted)
- 밀도
- 1.284±0.06 g/cm3(Predicted)
- 저장 조건
- Refrigerator
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨)
- 물리적 상태
- 노란색 고체.
- 산도 계수 (pKa)
- 11.06±0.20(Predicted)
- 색상
- 밝은 노란색에서 밝은 녹색까지
- InChIKey
- XZXHXSATPCNXJR-ZIADKAODSA-N
- SMILES
- C(/C1C=CC=CC=1)(=C1\C(NC2=CC(C(=O)OC)=CC=C\12)=O)\NC1C=CC(N(C)C(=O)CN2CCN(C)CC2)=CC=1
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
유해 물질 데이터 | 656247-17-5(Hazardous Substances Data) |
---|
Nintedanib C화학적 특성, 용도, 생산
정의
ChEBI: A member of the class of oxindoles that is a kinase inhibitor used (in the form of its ethylsulfonate salt) for the treatment of idiopathic pulmonary fibrosis and cancer.부작용
The most common side effects of Nintedanib in clinical studies were gastrointestinal-related side effects, including nausea (31%), vomiting (23%), diarrhoea (76%), abdominal pain (10%) and decreased appetite (10%). Other side effects were hepatic impairment commonly seen as elevated liver enzymes, weight loss (7 per cent), nasopharyngitis (7 per cent), cough (14 per cent), upper respiratory tract infections (14 per cent), headache (12 per cent), fatigue (14 per cent), skin ulcers (16 per cent) and urinary tract infections (12 per cent).Reported post-marketing adverse events include gastrointestinal perforation, proteinuria and pancreatitis. In several clinical trials, nidanib has also been found to be associated with an increased risk of bleeding, possibly secondary to VEGFR inhibition. Although serious bleeding and arterial thromboembolic events (e.g., myocardial infarction (MI) and stroke) are rare, bleeding events with serious and fatal consequences have been reported in post-marketing surveillance. Therefore, the use of nidazanib has been associated with an increased risk of bleeding, possibly secondary to VEGFR inhibition. Therefore, patients treated with nidazanib and receiving full anticoagulation therapy need to be closely monitored for adverse bleeding events.
Nintedanib 준비 용품 및 원자재
원자재
N-(4-아미노페닐)-N-메틸-2-(4-메틸피페라진-1-일)아세트아미드
(E)-메틸1-아세틸-3-(메톡시(페닐)메틸렌)-2-옥소인돌린-6-카르복실레이트
Nintedanib esylate
2,3-디하이드로-3-(메톡시페닐메틸렌)-2-옥소-1H-인돌-6-카르복실산메틸에스테르
1-Acetyl-3-(ethoxyphenylmethylene)-2,3-dihydro-2-oxo-1H-indole-6-carboxylic acid methyl ester
(3E)-2,3-디히드로-3-(메톡시페닐메틸렌)-2-옥소-1H-인돌-6-카르복실산메틸에스테르
Nintedanib Impurity 15
준비 용품
Nintedanib 공급 업체
글로벌( 383)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
SyncoZymes (Shanghai) Co., Ltd., | +86-021-68187180-811 +86-13681683526 |
lchen@syncozymes.com | China | 188 | 58 |
HangZhou RunYan Pharma Technology Co.,LTD. | +86-88660901 +86-18112526015 |
sales@runyanpharma.com | China | 326 | 58 |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 |
masar@topule.com | China | 8474 | 58 |
Hebei Mojin Biotechnology Co., Ltd | +8613288715578 |
sales@hbmojin.com | China | 12470 | 58 |
Hebei Yanxi Chemical Co., Ltd. | +8617531190177 |
peter@yan-xi.com | China | 6011 | 58 |
shandong perfect biotechnology co.ltd | +86-53169958659; +8618596095638 |
sales@sdperfect.com | China | 294 | 58 |
Hangzhou ICH Biofarm Co., Ltd | +86-0571-28186870; +undefined8613073685410 |
sales@ichemie.com | China | 985 | 58 |
Hangzhou Hyper Chemicals Limited | +86-0086-57187702781 +8613675893055 |
info@hyper-chem.com | China | 136 | 58 |
hebei hongtan Biotechnology Co., Ltd | +86-86-1913198-3935 +8617331935328 |
sales03@chemcn.cn | China | 966 | 58 |
Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 |
sales@capotchem.com | China | 29797 | 60 |
Nintedanib 관련 검색:
Infigratinib
Trametinib
Sunitinib Malate
Ibrutinib
Crizotinib
Neratinib
LEE011
Alectinib Hydrochloride
Nintedanib Ethanesulfonate Salt
Olaparib
EAI-045
PLX-4720
Alectinib
1,3-DiMethyl 2-[4-(Methoxycarbonyl)-2-nitrophenyl]propanedioate
1-Chloro-4-(trimethoxymethyl)benzene
Nintedanib Impurity 76
ALPHA,ALPHA,2,4-TETRACHLOROTOLUENE
1-ACETYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-5-CARBOXYLIC ACID METHYL ESTER